The highly transmissible omicron subvariant BA.5 will likely spur another wave of COVID-19 infections in the U.S., Eric Topol, MD, founder and director of the Scripps Research Translational Institute in San Diego, told The New York Times.
Read the full post on Becker's Hospital Review - Healthcare News
